Robert T Roeven

age ~52

from Stoughton, WI

Also known as:
  • Robert Tp Roeven
  • Robert F Roeven
  • Robert L Roeven
  • Robert P Roeven
  • Robert T Roevan

Robert Roeven Phones & Addresses

  • Stoughton, WI
  • Phillips, WI
  • Madison, WI
  • Johnston, IA
  • Dane, WI
  • 324 Lowell St, Stoughton, WI 53589 • 6085741035

Work

  • Company:
    Hologic
  • Position:
    Senior manager & principal scientist

Education

  • Degree:
    High school graduate or higher

Industries

Biotechnology

Resumes

Robert Roeven Photo 1

Senior Manager & Principal Scientist At Hologic

view source
Position:
Senior Manager & Principal Scientist at Hologic
Location:
Madison, Wisconsin Area
Industry:
Biotechnology
Work:
Hologic
Senior Manager & Principal Scientist
Name / Title
Company / Classification
Phones & Addresses
Robert Roeven
Scientist
THIRD WAVE TECHNOLOGIES, INC
Mfg Diagnostic Substances · Research & Development in Biotechnology
502 S Rosa Rd, Madison, WI 53719
209 W Washington St, Charleston, WV 25302
Madison, WI 53719
6082738933, 4254688206, 6086634011

Us Patents

  • Direct Nucleic Acid Detection In Bodily Fluids

    view source
  • US Patent:
    20050186588, Aug 25, 2005
  • Filed:
    Oct 18, 2004
  • Appl. No.:
    10/967711
  • Inventors:
    Victor Lyamichev - Madison WI, US
    Andrew Lukowiak - Stoughton WI, US
    Nancy Jarvis - Madison WI, US
    David Kurensky - Milwaukee WI, US
    Hatim Allawi - Madison WI, US
    Scott Law - Madison WI, US
    Chad Gerber - Middleton WI, US
    Robert Roeven - Stoughton WI, US
    Jeff Hall - Madison WI, US
  • International Classification:
    C12Q001/68
    C12P019/34
  • US Classification:
    435006000, 435091200
  • Abstract:
    The present invention provides methods and routines for developing and optimizing nucleic acid detection assays for use in basic research, clinical research, and for the development of clinical detection assays. In particular, the present invention provides methods for designing oligonucleotide primers to be used in multiplex amplification reactions. The present invention also provides methods to optimize multiplex amplification reactions. The present invention also provides methods for combined target and signal generation assays.
  • Cftr Allele Detection Assays

    view source
  • US Patent:
    20060147938, Jul 6, 2006
  • Filed:
    Nov 14, 2003
  • Appl. No.:
    10/713653
  • Inventors:
    Molly Accola - Madison WI, US
    Susan Wigdal - Madison WI, US
    Andrea Mast - Oregon WI, US
    Christian Bartholomay - Madison WI, US
    Robert Kwiatkowski - Verona WI, US
    Vincent Tevere - Madison WI, US
    Hon Ip - Madison WI, US
    Kathleen Carroll - Verona WI, US
    Patrick Peterson - Sun Prairie WI, US
    Poonam Agarwal - Madison WI, US
    Nancy Jarvis - Madison WI, US
    Jeff Hall - Madison WI, US
    Robert Roeven - Stoughton WI, US
  • Assignee:
    Third Wave Technologies, Inc. - Madison WI
  • International Classification:
    C12Q 1/68
    C07H 21/04
  • US Classification:
    435006000, 536024300
  • Abstract:
    The present invention provides compositions and methods for the detection and characterization of mutations associated with cystic fibrosis. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the CFTR gene associated with cystic fibrosis. The present invention also provides compositions, methods and kits for screening sets of CFTR alleles in a single reaction container.
  • Flourecent Quinacridone Derivatives

    view source
  • US Patent:
    20060240452, Oct 26, 2006
  • Filed:
    Feb 13, 2006
  • Appl. No.:
    11/352612
  • Inventors:
    Zbigniev Skrzypczynski - Verona WI, US
    Robert Roeven - Stoughton WI, US
  • International Classification:
    C12Q 1/68
    C07H 21/02
    C07D 471/02
  • US Classification:
    435006000, 536025320, 546049000, 546021000
  • Abstract:
    The present invention relates to methods and compositions utilizing fluorescent quinacridone derivatives. In particular, the present invention relates to the use of fluorescent quinacridone derivatives for the labeling and detection of riucleic acids. The present invention thus provides improved compositions and methods for labeling biological molecules useful in the detection of nucleic acids and other biological molecules.
  • Nucleic Acid Detection In Pooled Samples

    view source
  • US Patent:
    20080015112, Jan 17, 2008
  • Filed:
    Feb 15, 2006
  • Appl. No.:
    11/355090
  • Inventors:
    Lance Fors - Madison WI, US
    Bruce Neri - Madison WI, US
    Mary Brow - Madison WI, US
    Monika Indig - Madison WI, US
    Robert Roeven - Stoughton WI, US
  • International Classification:
    C40B 20/04
  • US Classification:
    506004000
  • Abstract:
    The present invention relates to detecting target nucleic acid sequences in pooled samples. In particular, the present invention relates to compositions and methods for detecting the presence or absence of target nucleic acid sequences (e.g. RNA virus sequences) in a pooled sample employing an INVADER detection assay. In certain embodiments, the present invention allows target nucleic acid sequence detection in pooled biological samples (e.g. pooled blood samples) without prior amplification of the target.
  • Nucleic Acid Detection In Pooled Samples

    view source
  • US Patent:
    20030152942, Aug 14, 2003
  • Filed:
    May 9, 2002
  • Appl. No.:
    10/142283
  • Inventors:
    Lance Fors - Madison WI, US
    Bruce Neri - Madison WI, US
    Mary D. Brow - Madison WI, US
    Monika Indig - Madison WI, US
    Robert Roeven - Stoughton WI, US
  • International Classification:
    C12Q001/70
    C12Q001/68
  • US Classification:
    435/006000, 435/005000
  • Abstract:
    The present invention relates to detecting target nucleic acid sequences in pooled samples. In particular, the present invention relates to compositions and methods for detecting the presence or absence of target nucleic acid sequences (e.g. RNA virus sequences) in a pooled sample employing an INVADER detection assay. In certain embodiments, the present invention allows target nucleic acid sequence detection in pooled biological samples (e.g. pooled blood samples) without prior amplification of the target.
  • Transportable Composite Liquid Cells

    view source
  • US Patent:
    20160193607, Jul 7, 2016
  • Filed:
    Nov 25, 2014
  • Appl. No.:
    14/916947
  • Inventors:
    - Raheen, County Limerick, IE
    David McGuire - Enniscorthy, County Wexford, IE
    Robert Roeven - Stoughton WI, US
  • International Classification:
    B01L 3/00
    C12Q 1/68
    G01N 35/10
    B01L 7/00
  • Abstract:
    A single-use cartridge, wherein the cartridge defines a plurality of blind bores, each blind bore defining one opening at least one of the plurality of blind bores containing two mutually immiscible liquids, both of which are immiscible with water, one of the two mutually immiscible liquids having a specific gravity greater than water and the other of the two mutually immiscible liquids having a specific gravity less than water.
  • Biomolecule Isolation And Thermal Processing

    view source
  • US Patent:
    20160102341, Apr 14, 2016
  • Filed:
    Jun 18, 2014
  • Appl. No.:
    14/892695
  • Inventors:
    - Limerick, IE
    Robert Roeven - Stoughton WI, US
  • International Classification:
    C12Q 1/68
    G01N 35/10
    G01N 35/00
  • Abstract:
    Methods, devices and systems for hand-tag sample liquids, encapsulating liquids and magnetic particles are disclosed.

Get Report for Robert T Roeven from Stoughton, WI, age ~52
Control profile